ACE and glaucoma: In addition, an animal study using a rodent model of glaucoma found that angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists may have a beneficial effect on RGC survival45, suggesting that RAS may modulate RGC survival through exerting a neuroprotective effect.